These findings are in accordance with the discussed increased pathogenicity of Fc hypoglycosylated ACPAs and total IgG reported in pre-RA and RA (190, 191), as well as with the observation that RA patients with lower IgG and ACPA sialylation had more bone loss (232). This evidence concerns the gene PRTN3 and rheumatoid arthritis.